The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines

被引:0
|
作者
Do Nyun Kim
Yoon-Jae Song
Suk Kyeong Lee
机构
[1] Research Institute of Immunobiology,Department of Medical Lifescience
[2] College of Medicine,Department of Life Science
[3] The Catholic University of Korea,undefined
[4] Seoul 137-701,undefined
[5] Korea.,undefined
[6] Kyungwon University,undefined
[7] Seongnam 461-701,undefined
[8] Korea.,undefined
来源
关键词
decitabine; DNA methylation; Herpesvirus 4, human; microRNAs; promoter regions, genetic;
D O I
暂无
中图分类号
学科分类号
摘要
Epstein-Barr virus (EBV) microRNAs (miRNAs) are expressed in EBV-associated tumors and cell lines, but the regulation mechanism of their expression is unclear yet. We investigated whether the expression of EBV miRNAs is epigenetically regulated in EBV-infected B cell lines. The expression of BART miRNAs was inversely related with the methylation level of the BART promoter at both steady-state and following 5-aza-2'-deoxycytidine treatment of the cells. The expression of BHRF1 miRNAs also became detectable with the demethylation of Cp/Wp in latency I EBV-infected cell lines. Furthermore, in vitro methylation of the BART and Cp promoters reduced the promoter-driven transactivation. In contrast, tricostatin A had little effect on the expression of EBV miRNA expression as well as on the BART and Cp/Wp promoters. Our results suggest that promoter methylation, but not histone acetylation, plays a role in regulation of the EBV miRNA expression in EBV-infected B cell lines.
引用
收藏
页码:401 / 410
页数:9
相关论文
共 50 条
  • [41] Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain
    Trivedi, P
    Spinsanti, P
    Cuomo, L
    Volpe, M
    Takada, K
    Frati, L
    Faggioni, A
    JOURNAL OF VIROLOGY, 2001, 75 (10) : 4929 - 4935
  • [42] Epstein-Barr Virus (EBV) gene expression during infectious mononucleosis
    Schuster, V
    Pukrop, T
    Seidenspinner, S
    Schöntube, M
    MONATSSCHRIFT KINDERHEILKUNDE, 1999, 147 (10) : 917 - +
  • [43] Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease
    Ohshima, K
    Suzumiya, J
    Kanda, M
    Kato, A
    Kikuchi, M
    CANCER LETTERS, 1998, 122 (1-2) : 43 - 50
  • [44] Epstein-Barr Virus (EBV) DNA in sera of patients with primary EBV infection
    Chan, KH
    Ng, MH
    Seto, WH
    Peiris, JSM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) : 4152 - 4154
  • [45] Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies
    Sidagis, J
    Ueno, K
    Tokunaga, M
    Ohyama, M
    Eizuru, Y
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (01) : 72 - 76
  • [46] Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers
    Teow, Sin-Yeang
    Liew, Kitson
    Khoo, Alan Soo-Beng
    Peh, Suat-Cheng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (10): : 1276 - 1286
  • [47] The pathogenic role of Epstein-Barr virus (EBV) in sclerosing polycystic adenosis
    Swelam, Wael M.
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (08) : 565 - 571
  • [48] Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes
    Klein, George
    Klein, Eva
    Kashuba, Elena
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (01) : 67 - 73
  • [49] The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia
    Wu, Zhong
    Zhou, Jin
    Wei, Xiaoxia
    Wang, Xin
    Li, Yongbin
    Peng, Bing
    Niu, Ting
    HEMATOLOGY, 2013, 18 (05) : 295 - 299
  • [50] ASSESSMENT OF SURFACE MARKERS OF HUMAN LYMPHOBLAST CELL LINES AND EPSTEIN-BARR VIRUS (EBV) GENOME
    YOUNT, W
    UTSINGER, P
    HUTT, L
    BUCHANAN, P
    KORN, J
    PAGANO, J
    CLINICAL RESEARCH, 1976, 24 (03): : A339 - A339